The emerging treatment landscape in ATTR amyloidosis: what’s on the horizon?

ESC Premium Access

The emerging treatment landscape in ATTR amyloidosis: what’s on the horizon?

Session: Amyloidosis beyond heart failure: paving the way for an early diagnosis

Topic: Chronic Heart Failure, Other

Speaker: Professor C. Rapezzi (Ferrara, IT)

Organised by Medscape Education, supported by independent educational grants from Akcea Therapeutics, Alnylam Pharmaceuticals, Inc., and Eidos Therapeutics, Inc.

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Professor Claudio Rapezzi

University of Ferrara, Ferrara (Italy)

29 presentations

3 followers

4 more presentations in this session

Welcome and introduction - Amyloidosis beyond heart failure: paving the way for an early diagnosis.

Speaker: Doctor M. Grogan (Rochester, US)

Access

Delayed diagnosis of amyloidosis: what if the patient does not have heart failure?

Speaker: Doctor M. Grogan (Rochester, US)

Access

Managing amyloidosis in cardiology practice: a call for collaboration.

Speaker: Doctor M. Maurer (New York, US)

Access

Panel discussion and question and answer session - Amyloidosis beyond heart failure: paving the way for an early diagnosis.

Speaker: Doctor M. Grogan (Rochester, US)

Access

Access the full session

Amyloidosis beyond heart failure: paving the way for an early diagnosis

Speakers: Professor C. Rapezzi, Doctor M. Grogan, Doctor M. Grogan, Doctor M. Maurer, Doctor M. Grogan

Access

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources